Companies that own DexCom Inc.
The Vanguard Group, Inc.
7,073,489
8.01%
-20,208
0.03%
06/30/2018
Fidelity Management & Research Co.
7,045,928
7.97%
-223,280
0.1%
06/30/2018
T. Rowe Price Associates, Inc.
5,581,568
6.32%
-3,349,864
0.11%
06/30/2018
Baillie Gifford & Co.
5,198,067
5.88%
-219,757
0.47%
06/30/2018
Capital Research & Management Co. (World Investors)
5,175,000
5.86%
-88,000
0.11%
06/30/2018
Morgan Stanley Investment Management, Inc.
4,823,598
5.46%
629,104
0.94%
06/30/2018
Henderson Global Investors Ltd.
4,442,373
5.03%
-2,473,918
0.28%
06/30/2018
Wellington Management Co. LLP
3,805,226
4.3%
-246,653
0.1%
07/31/2018
BlackRock Fund Advisors
3,752,783
4.25%
65,850
0.03%
06/30/2018
Brown Advisory LLC
3,180,090
3.6%
-405,095
1.33%
06/30/2018
| Address |
6340 Sequence Drive
San Diego California 92121
United States
|
|
Employees
|
- |
| Website |
http://www.dexcom.com |
| Updated |
07/08/2019 |
| DexCom, Inc. is a medical device manufacturing company, which engages in the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G4 PLATINUM System, Dexcom studio and Mobile apps. The company was founded by John F. |
